My work focuses on trends in the development and regulation of new pharmaceutical products including the impact of legislative and regulatory initiatives designed to speed the process of new drug development and review. I am particularly interested in the economic, legal, scientific, and political factors that contribute to the slow pace and high cost of pharmaceutical R&D, and on new models of bio/pharmaceutical innovation. I also play an important role in the MS in Development and Regulation of Medicines and Devices, a program based in the Public Health and Professional Degree Programs unit at Tufts School of Medicine.

Learn more about The Center for the Study of Drug Development.